474 related articles for article (PubMed ID: 17913795)
21. Separation and characterization of active flavonolignans of Silybum marianum by liquid chromatography connected with hybrid ion-trap and time-of-flight mass spectrometry (LC-MS/IT-TOF).
Shibano M; Lin AS; Itokawa H; Lee KH
J Nat Prod; 2007 Sep; 70(9):1424-8. PubMed ID: 17764149
[TBL] [Abstract][Full Text] [Related]
22. Isolation and purification of diastereoisomeric flavonolignans from silymarin by binary-column recycling preparative high-performance liquid chromatography.
Zhao W; Yang G; Zhong F; Yang N; Zhao X; Qi Y; Fan G
J Sep Sci; 2014 Sep; 37(17):2300-6. PubMed ID: 24923482
[TBL] [Abstract][Full Text] [Related]
23. Skin Protective Activity of Silymarin and its Flavonolignans.
Vostálová J; Tinková E; Biedermann D; Kosina P; Ulrichová J; Rajnochová Svobodová A
Molecules; 2019 Mar; 24(6):. PubMed ID: 30875758
[No Abstract] [Full Text] [Related]
24. Molecular structure and stereochemistry of silybin A, silybin B, isosilybin A, and isosilybin B, Isolated from Silybum marianum (milk thistle).
Lee DY; Liu Y
J Nat Prod; 2003 Sep; 66(9):1171-4. PubMed ID: 14510591
[TBL] [Abstract][Full Text] [Related]
25. Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C.
Schrieber SJ; Hawke RL; Wen Z; Smith PC; Reddy KR; Wahed AS; Belle SH; Afdhal NH; Navarro VJ; Meyers CM; Doo E; Fried MW
Drug Metab Dispos; 2011 Dec; 39(12):2182-90. PubMed ID: 21865319
[TBL] [Abstract][Full Text] [Related]
26. Biotransformation of Silymarin Flavonolignans by Human Fecal Microbiota.
Valentová K; Havlík J; Kosina P; Papoušková B; Jaimes JD; Káňová K; Petrásková L; Ulrichová J; Křen V
Metabolites; 2020 Jan; 10(1):. PubMed ID: 31936497
[TBL] [Abstract][Full Text] [Related]
27. A silychristin isomer and variation of flavonolignan levels in milk thistle (Silybum marianum) fruits.
Smith WA; Lauren DR; Burgess EJ; Perry NB; Martin RJ
Planta Med; 2005 Sep; 71(9):877-80. PubMed ID: 16206045
[TBL] [Abstract][Full Text] [Related]
28. Gram-scale purification of flavonolignan diastereoisomers from Silybum marianum (Milk Thistle) extract in support of preclinical in vivo studies for prostate cancer chemoprevention.
Graf TN; Wani MC; Agarwal R; Kroll DJ; Oberlies NH
Planta Med; 2007 Nov; 73(14):1495-501. PubMed ID: 17948171
[TBL] [Abstract][Full Text] [Related]
29. A validated UHPLC-tandem mass spectrometry method for quantitative analysis of flavonolignans in milk thistle (Silybum marianum) extracts.
Graf TN; Cech NB; Polyak SJ; Oberlies NH
J Pharm Biomed Anal; 2016 Jul; 126():26-33. PubMed ID: 27136284
[TBL] [Abstract][Full Text] [Related]
30. Milk thistle in liver diseases: past, present, future.
Abenavoli L; Capasso R; Milic N; Capasso F
Phytother Res; 2010 Oct; 24(10):1423-32. PubMed ID: 20564545
[TBL] [Abstract][Full Text] [Related]
31. Drug-drug interactions of silymarin on the perspective of pharmacokinetics.
Wu JW; Lin LC; Tsai TH
J Ethnopharmacol; 2009 Jan; 121(2):185-93. PubMed ID: 19041708
[TBL] [Abstract][Full Text] [Related]
32. Supercritical CO₂ extraction of oil, fatty acids and flavonolignans from milk thistle seeds: Evaluation of their antioxidant and cytotoxic activities in Caco-2 cells.
Ben Rahal N; Barba FJ; Barth D; Chevalot I
Food Chem Toxicol; 2015 Sep; 83():275-82. PubMed ID: 26172510
[TBL] [Abstract][Full Text] [Related]
33. The effects of milk thistle (Silybum marianum) on human cytochrome P450 activity.
Kawaguchi-Suzuki M; Frye RF; Zhu HJ; Brinda BJ; Chavin KD; Bernstein HJ; Markowitz JS
Drug Metab Dispos; 2014 Oct; 42(10):1611-6. PubMed ID: 25028567
[TBL] [Abstract][Full Text] [Related]
34. Silybin, a Major Bioactive Component of Milk Thistle (Silybum marianum L. Gaernt.)-Chemistry, Bioavailability, and Metabolism.
Bijak M
Molecules; 2017 Nov; 22(11):. PubMed ID: 29125572
[TBL] [Abstract][Full Text] [Related]
35. Accumulation of silymarin in milk thistle seeds under drought stress.
Keshavarz Afshar R; Chaichi MR; Ansari Jovini M; Jahanzad E; Hashemi M
Planta; 2015 Sep; 242(3):539-43. PubMed ID: 25708739
[TBL] [Abstract][Full Text] [Related]
36. Silybin and its congeners: from traditional medicine to molecular effects.
Křen V; Valentová K
Nat Prod Rep; 2022 Jun; 39(6):1264-1281. PubMed ID: 35510639
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the Cytotoxicity and Genotoxicity of Flavonolignans in Different Cellular Models.
Bijak M; Synowiec E; Sitarek P; Sliwiński T; Saluk-Bijak J
Nutrients; 2017 Dec; 9(12):. PubMed ID: 29240674
[TBL] [Abstract][Full Text] [Related]
38. Relative Bioavailability of Silybin A and Silybin B From 2 Multiconstituent Dietary Supplement Formulations Containing Milk Thistle Extract: A Single-dose Study.
Li WY; Yu G; Hogan RM; Mohandas R; Frye RF; Gumpricht E; Markowitz JS
Clin Ther; 2018 Jan; 40(1):103-113.e1. PubMed ID: 29273470
[TBL] [Abstract][Full Text] [Related]
39. Hepatic metabolism and biliary excretion of silymarin flavonolignans in isolated perfused rat livers: role of multidrug resistance-associated protein 2 (Abcc2).
Miranda SR; Lee JK; Brouwer KL; Wen Z; Smith PC; Hawke RL
Drug Metab Dispos; 2008 Nov; 36(11):2219-26. PubMed ID: 18687803
[TBL] [Abstract][Full Text] [Related]
40. Two flavonolignans from milk thistle (Silybum marianum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrations.
Brantley SJ; Oberlies NH; Kroll DJ; Paine MF
J Pharmacol Exp Ther; 2010 Mar; 332(3):1081-7. PubMed ID: 19934397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
